Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Zhengzhou UniversityActive in the last 2 years

Yihui Ma

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0003-2782-394X; OpenAlex author ID A5100971238.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 2, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression. First author DOI 10.1186/s12967-024-05970-6↗
  2. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1. First author DOI 10.1016/j.neo.2021.07.004↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Kuisheng Chen · 1 shared paper, 2024
  2. Yanan Jiang · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.